Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure Drugs: Diuretics

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...

Heart Failure Drugs: Inotropic Agents

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...

Heart Failure VII: Nursing Interventions

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...

Heart Failure I: Introduction

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Isolated right ventricular failure and abnormal hemodynamics caused by right ventricular pacing are reversed with cardiac resynchronization therapy.

HeartRhythm case reports·2017

Same author

Physical Examination Is Still Necessary and Important.

JACC. Cardiovascular imaging·2015

Same author

A second look with prone SPECT myocardial perfusion imaging reduces the need for angiography in patients at low risk for cardiac death or MI.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2014

Same author

When would the assessment of fractional flow reserve be nonreproducible?

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2014

Same author

The pulmonary artery catheter: a critical reappraisal.

Cardiology clinics·2013

Same author

Coronary collateral circulation: its relevance.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2013

Search research articles

Related Experiment Videos

Hyponatremia in heart failure.

Kanu Chatterjee¹

¹University of California, San Francisco, California, USA. chatterj@medicine.ucsf.edu

Journal of Intensive Care Medicine

|October 24, 2009

Summary

Hyponatremia, or low serum sodium, is an emerging risk factor for poor outcomes in chronic heart failure. Current treatments are often ineffective, and long-term benefits of newer therapies remain uncertain.

Area of Science:

Cardiology
Nephrology
Internal Medicine

Background:

Hyponatremia (low serum sodium) is increasingly recognized as a significant risk factor for adverse prognosis in patients with chronic heart failure.
The precise mechanisms linking hyponatremia to worsened heart failure outcomes and the underlying pathophysiology of sodium imbalance in this condition are not fully understood.
Existing treatments for significant hyponatremia in heart failure, including fluid restriction, hypertonic saline, and diuretics, often prove insufficient.

Purpose of the Study:

To explore the prognostic implications of hyponatremia in chronic heart failure.
To elucidate the potential mechanisms contributing to hyponatremia in heart failure.
To review the challenges and effectiveness of current and emerging therapeutic strategies for hyponatremia in this patient population.

Related Experiment Videos

Main Methods:

Review of existing literature on hyponatremia in chronic heart failure.
Analysis of proposed pathophysiological mechanisms, including neurohormonal activation and free water retention.
Evaluation of the efficacy and limitations of conventional and pharmacological treatments, such as vasopressin receptor antagonists.

Main Results:

Hyponatremia is associated with a worse prognosis in chronic heart failure, potentially reflecting disease severity and neurohormonal dysregulation.
The primary mechanism is likely disproportionate free water retention over sodium retention.
Conventional therapies show limited effectiveness, while vasopressin receptor antagonists demonstrate potential for correcting hyponatremia via aquaresis, though long-term benefits require further study.

Conclusions:

Hyponatremia represents a critical emerging risk factor in chronic heart failure with unclear underlying mechanisms and difficult treatment scenarios.
Further research is needed to clarify the long-term efficacy and impact of novel treatments like vasopressin receptor antagonists on chronic heart failure prognosis.